| Mr David Aaron Guthman, MD | |
|
880 W Central Rd Ste 5000, Arlington Heights, IL 60005-2355 | |
| (847) 618-3800 | |
| (847) 618-3809 |
| Full Name | Mr David Aaron Guthman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | 880 W Central Rd Ste 5000, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073585436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 036088290 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Community Health Services Inc | 3375737331 | 275 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
| Entity Name | United Shockwave Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497132377 PECOS PAC ID: 8729984448 Enrollment ID: O20031211000738 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
| Entity Name | Northwest United Urology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063643252 PECOS PAC ID: 0345383691 Enrollment ID: O20100209000061 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
| Entity Name | Northwest Community Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134433154 PECOS PAC ID: 3375737331 Enrollment ID: O20101103000837 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Aaron Guthman, MD 880 W Central Rd Ste 5000, Arlington Heights, IL 60005-2355 Ph: (847) 618-3800 | Mr David Aaron Guthman, MD 880 W Central Rd Ste 5000, Arlington Heights, IL 60005-2355 Ph: (847) 618-3800 |
News Archive
Late last week, the president and his deputies were linking parts of the health law and opportunities as part of their effort to draw support from women voters. At the same time, The Associated Press reports on the challenges GOP presidential hopeful Mitt Romney faces in his attempts to bridge the gender gap.
Under a new program created by the health law, hospitals can get larger payments - or payment cuts - based on the quality of care they provide.
Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS(R) Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO(R) liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.
Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).
New research from Keele University has highlighted the key challenges that workers in the social care sector faced during the first wave of Covid-19.
› Verified 8 days ago
Dr. April Adams Szafran, MD, PHD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Phuong N Huynh, MD, MPH Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd Ste 150, Arlington Heights, IL 60005 Phone: 630-790-1221 | |
Dr. Michael James Ross, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Humberto Joseph Martinez-suarez, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Sarah Martin, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Arlington Heights Rd Ste 150, Arlington Heights, IL 60005 Phone: 847-439-4343 Fax: 847-439-4510 | |
Mr. Jerrold Howard Seckler, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 880 W. Central Road, Suite 5200, Arlington Heights, IL 60005 Phone: 847-259-2410 Fax: 847-259-8603 |